'Parp inhibition' presentation slideshows

Perspectives on PARP Inhibitors in Ovarian Cancer Has the Time Come for Individualized Care?

Perspectives on PARP Inhibitors in Ovarian Cancer Has the Time Come for Individualized Care?. Activity Goals. Epidemiology: Ovarian Cancer. PARP and DNA Repair. BRCA and DNA Repair. Synthetic Lethality Is Associated With Inhibition of PARP in the Presence of BRCA Deficiency.

701 views • 38 slides

1 Moulder S et al. Proc SABCS 2010;Abstract P6-15-01.

251 views • 16 slides

Shivaani Kummar, MD National Cancer Institute June 3, 2007

168 views • 16 slides

Shivaani Kummar, MD National Cancer Institute September 5, 2007

Inhibition of Poly (ADP-Ribose) Polymerase (PARP) by ABT-888 in Patients With Advanced Malignancies: Results of a Phase 0 Trial. Shivaani Kummar, MD National Cancer Institute September 5, 2007. Objectives. Primary :

159 views • 15 slides